RU2018125932A3 - - Google Patents

Download PDF

Info

Publication number
RU2018125932A3
RU2018125932A3 RU2018125932A RU2018125932A RU2018125932A3 RU 2018125932 A3 RU2018125932 A3 RU 2018125932A3 RU 2018125932 A RU2018125932 A RU 2018125932A RU 2018125932 A RU2018125932 A RU 2018125932A RU 2018125932 A3 RU2018125932 A3 RU 2018125932A3
Authority
RU
Russia
Application number
RU2018125932A
Other languages
Russian (ru)
Other versions
RU2018125932A (ru
RU2789479C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/735,973 external-priority patent/US8765725B2/en
Application filed filed Critical
Publication of RU2018125932A publication Critical patent/RU2018125932A/ru
Publication of RU2018125932A3 publication Critical patent/RU2018125932A3/ru
Application granted granted Critical
Publication of RU2789479C2 publication Critical patent/RU2789479C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/009—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by only one oxygen atom doubly bound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2018125932A 2012-05-08 2013-05-06 Препараты гидрофобных терапевтических средств, способы их получения и применения RU2789479C2 (ru)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US201261644105P 2012-05-08 2012-05-08
US61/644,105 2012-05-08
US201261657239P 2012-06-08 2012-06-08
US61/657,239 2012-06-08
US201261692487P 2012-08-23 2012-08-23
US61/692,487 2012-08-23
US13/735,973 2013-01-07
US13/735,973 US8765725B2 (en) 2012-05-08 2013-01-07 Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
US201361763770P 2013-02-12 2013-02-12
US61/763,770 2013-02-12
US201361788519P 2013-03-15 2013-03-15
US61/788,519 2013-03-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2014149115A Division RU2663117C2 (ru) 2012-05-08 2013-05-06 Препараты гидрофобных терапевтических средств, способы их получения и применения

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2023101909A Division RU2023101909A (ru) 2012-05-08 2023-01-30 Препараты гидрофобных терапевтических средств, способы их получения и применения

Publications (3)

Publication Number Publication Date
RU2018125932A RU2018125932A (ru) 2019-03-12
RU2018125932A3 true RU2018125932A3 (cg-RX-API-DMAC10.html) 2022-01-20
RU2789479C2 RU2789479C2 (ru) 2023-02-03

Family

ID=

Also Published As

Publication number Publication date
JP2015520149A (ja) 2015-07-16
JP2020189877A (ja) 2020-11-26
BR112014027681A2 (pt) 2017-06-27
RU2018125932A (ru) 2019-03-12
ES2813397T3 (es) 2021-03-23
EP3741772A1 (en) 2020-11-25
EP2847207A4 (en) 2015-11-11
US10174071B2 (en) 2019-01-08
PT3517541T (pt) 2020-08-28
MX386182B (es) 2025-03-18
US10954263B2 (en) 2021-03-23
EP3741772B1 (en) 2024-06-19
CA2872845A1 (en) 2013-11-14
CN104350063A (zh) 2015-02-11
EP3741772C0 (en) 2024-06-19
US11814408B2 (en) 2023-11-14
CA2872845C (en) 2021-11-09
US20180022775A1 (en) 2018-01-25
ES2727474T3 (es) 2019-10-16
CN107880091B (zh) 2020-12-18
EP3517541B1 (en) 2020-07-15
US20190169224A1 (en) 2019-06-06
MX2014013523A (es) 2015-10-22
PL3517541T3 (pl) 2020-12-28
WO2013169647A1 (en) 2013-11-14
US20210300963A1 (en) 2021-09-30
JP6564891B2 (ja) 2019-08-21
BR112014027681B1 (pt) 2023-02-14
JP6752940B2 (ja) 2020-09-09
KR20150013158A (ko) 2015-02-04
CN104350063B (zh) 2018-01-05
IN2014DN09326A (cg-RX-API-DMAC10.html) 2015-07-10
JP2019167382A (ja) 2019-10-03
EP2847207B1 (en) 2019-03-27
DK3517541T3 (da) 2020-09-07
KR102129426B1 (ko) 2020-07-02
RU2014149115A (ru) 2016-06-27
JP2018083846A (ja) 2018-05-31
JP6972255B2 (ja) 2021-11-24
BR112014027681B8 (pt) 2023-10-31
EP3517541A1 (en) 2019-07-31
AU2013259872A1 (en) 2014-11-27
HUE050993T2 (hu) 2021-01-28
CN107880091A (zh) 2018-04-06
JP6285419B2 (ja) 2018-02-28
MX361886B (es) 2018-12-18
HK1252481A1 (zh) 2019-05-24
RU2663117C2 (ru) 2018-08-01
AU2013259872B2 (en) 2018-06-28
ZA201408119B (en) 2016-08-31
EP2847207A1 (en) 2015-03-18
ES2983481T3 (es) 2024-10-23
HK1207087A1 (en) 2016-01-22

Similar Documents

Publication Publication Date Title
BR112014017635A2 (cg-RX-API-DMAC10.html)
BR112014017614A2 (cg-RX-API-DMAC10.html)
BR112014017625A2 (cg-RX-API-DMAC10.html)
BR112014017659A2 (cg-RX-API-DMAC10.html)
BR112014017592A2 (cg-RX-API-DMAC10.html)
BR112014017646A2 (cg-RX-API-DMAC10.html)
AR092201A1 (cg-RX-API-DMAC10.html)
BR112013027865A2 (cg-RX-API-DMAC10.html)
BR112014017609A2 (cg-RX-API-DMAC10.html)
BR112014017644A2 (cg-RX-API-DMAC10.html)
BR112014020183A2 (cg-RX-API-DMAC10.html)
BR112014017634A2 (cg-RX-API-DMAC10.html)
BR112014018153A2 (cg-RX-API-DMAC10.html)
BR112014017647A2 (cg-RX-API-DMAC10.html)
BR112014013184A8 (cg-RX-API-DMAC10.html)
BR112014018108A2 (cg-RX-API-DMAC10.html)
BR112014017627A2 (cg-RX-API-DMAC10.html)
BR112014017623A2 (cg-RX-API-DMAC10.html)
BR112014017630A2 (cg-RX-API-DMAC10.html)
BR112014017641A2 (cg-RX-API-DMAC10.html)
BR112014017621A2 (cg-RX-API-DMAC10.html)
BR112014017631A2 (cg-RX-API-DMAC10.html)
BR112014017622A2 (cg-RX-API-DMAC10.html)
BR112014017671A2 (cg-RX-API-DMAC10.html)
BR112014017589A2 (cg-RX-API-DMAC10.html)